SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,154.25 -388.19
( -0.49%)

Global Indices

Nasdaq

53,996.18 -61.75
(-0.11%)

Dow Jones

7,774.29 -4.35
(-0.06%)

Hang Seng

66,870.65 1,263.94
(1.93%)

Nikkei 225

10,869.98 -31.11
(-0.29%)

Forex

USD-INR

95.15 -0.05
(-0.05%)

EUR-INR

109.97 0.14
(0.13%)

GBP-INR

128.34 0.21
(0.16%)

JPY-INR

0.60 0.00
(0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Anuh Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506260

INE489G01022

35.1435185

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ANUHPHR

17.59

777.64

EPS(TTM)

Face Value()

Div & Yield %

4.41

1.93

Back

Cipla consolidated net profit declines 39.19% in the June 2026 quarter

Jul 23,2026

Net profit of Cipla declined 39.19% to Rs 789.05 crore in the quarter ended June 2026 as against Rs 1297.62 crore during the previous quarter ended June 2025. Sales rose 3.51% to Rs 7077.02 crore in the quarter ended June 2026 as against Rs 6837.04 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	7077.02	6837.04	4
OPM %	16.85	26.01	-
PBDT	1386.17	2022.65	-31
PBT	1081.93	1769.93	-39
NP	789.05	1297.62	-39

78,154.25 -388.19 ( -0.49%)

53,996.18 -61.75 (-0.11%)

7,774.29 -4.35 (-0.06%)

66,870.65 1,263.94 (1.93%)

10,869.98 -31.11 (-0.29%)

95.15 -0.05 (-0.05%)

109.97 0.14 (0.13%)

128.34 0.21 (0.16%)

0.60 0.00 (0.09%)